rexulti
(brexpiprazole)Otsuka America Pharmaceutical, Inc.
Usage: REXULTI is indicated as an adjunctive treatment for major depressive disorder in adults, for the treatment of schizophrenia in adults and patients aged 13 and older, and for agitation associated with Alzheimer's disease. It is not intended for as-needed treatment of agitation.